Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9172 |
High Similarity |
NPD7075 |
Discontinued |
0.8981 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8974 |
High Similarity |
NPD7411 |
Suspended |
0.8924 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8917 |
High Similarity |
NPD6801 |
Discontinued |
0.891 |
High Similarity |
NPD4380 |
Phase 2 |
0.8831 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD7819 |
Suspended |
0.872 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD6799 |
Approved |
0.8634 |
High Similarity |
NPD7768 |
Phase 2 |
0.8634 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8631 |
High Similarity |
NPD6559 |
Discontinued |
0.858 |
High Similarity |
NPD3749 |
Approved |
0.8562 |
High Similarity |
NPD1549 |
Phase 2 |
0.8562 |
High Similarity |
NPD1934 |
Approved |
0.8554 |
High Similarity |
NPD7473 |
Discontinued |
0.8553 |
High Similarity |
NPD6599 |
Discontinued |
0.8506 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD3818 |
Discontinued |
0.8497 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8457 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8452 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8424 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8405 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8366 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8343 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8282 |
Intermediate Similarity |
NPD2801 |
Approved |
0.825 |
Intermediate Similarity |
NPD920 |
Approved |
0.8239 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8239 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8239 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8239 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8232 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8224 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8217 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8217 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8187 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8153 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8153 |
Intermediate Similarity |
NPD2800 |
Approved |
0.814 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8125 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8113 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8077 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8077 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8046 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8035 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8035 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD919 |
Approved |
0.7974 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7919 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7818 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7809 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD37 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7751 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7738 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7711 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1203 |
Approved |
0.763 |
Intermediate Similarity |
NPD5710 |
Approved |
0.763 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7628 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD4287 |
Approved |
0.758 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7557 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7532 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6777 |
Approved |
0.75 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6190 |
Approved |
0.75 |
Intermediate Similarity |
NPD6776 |
Approved |
0.75 |
Intermediate Similarity |
NPD6780 |
Approved |
0.75 |
Intermediate Similarity |
NPD6778 |
Approved |
0.75 |
Intermediate Similarity |
NPD6779 |
Approved |
0.75 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7429 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7421 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD943 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7386 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7375 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7345 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7874 |
Approved |
0.733 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7316 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7289 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7289 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7283 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7273
|
Intermediate Similarity |
NPD8127 |
Discontinued |